Long-term outcome of lamivudine/dolutegravir dual therapy in HIV-infected, virologically suppressed patients

被引:0
|
作者
Franco Maggiolo
Roberto Gulminetti
Layla Pagnucco
Margherita Digaetano
Adriana Cervo
Daniela Valenti
Annapaola Callegaro
Cristina Mussini
机构
[1] ASST Papa Giovanni XXIII,Division of Infectious Diseases
[2] Fondazione IRCCS Policlinico San Matteo,Division of Infectious Diseases
[3] University of Modena,Division of Infectious Diseases
[4] ASST Papa Giovanni XXIII,Microbiology and Virology Laboratory
[5] Fondazione FROM,undefined
来源
BMC Infectious Diseases | / 22卷
关键词
Dual ART; Dolutegravir; Lamivudine; Switch; Simplification; Long-term follow-up; Cohort;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 50 条
  • [1] Long-term outcome of lamivudine/dolutegravir dual therapy in HIV-infected, virologically suppressed patients
    Maggiolo, Franco
    Gulminetti, Roberto
    Pagnucco, Layla
    Digaetano, Margherita
    Cervo, Adriana
    Valenti, Daniela
    Callegaro, Annapaola
    Mussini, Cristina
    BMC INFECTIOUS DISEASES, 2022, 22 (01)
  • [2] Lamivudine/dolutegravir dual therapy in HIV-infected, virologically suppressed patients
    Maggiolo, Franco
    Gulminetti, Roberto
    Pagnucco, Layla
    Digaetano, Margherita
    Benatti, Simone
    Valenti, Daniela
    Callegaro, Annapaola
    Ripamonti, Diego
    Mussini, Cristina
    BMC INFECTIOUS DISEASES, 2017, 17
  • [3] Lamivudine/dolutegravir dual therapy in HIV-infected, virologically suppressed patients
    Franco Maggiolo
    Roberto Gulminetti
    Layla Pagnucco
    Margherita Digaetano
    Simone Benatti
    Daniela Valenti
    Annapaola Callegaro
    Diego Ripamonti
    Cristina Mussini
    BMC Infectious Diseases, 17
  • [4] Virological control and metabolic improvement in HIV-infected, virologically suppressed patients switching to lamivudine/dolutegravir dual therapy
    Borghetti, A.
    Baldin, G.
    Ciccullo, A.
    Gagliardini, R.
    D'Avino, A.
    Mondi, A.
    Ciccarelli, N.
    Lamonica, S.
    Fanti, I.
    Trecarichi, E.
    Fabbiani, M.
    Cauda, R.
    De Luca, A.
    Di Giambenedetto, S.
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2016, 71 (08) : 2359 - 2361
  • [5] Virological efficacy of dual therapy with lamivudine and dolutegravir in HIV-1-infected virologically suppressed patients: long-term data from clinical practice
    Baldin, Gianmaria
    Ciccullo, Arturo
    Borghetti, Alberto
    Di Giambenedetto, Simona
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2019, 74 (05) : 1461 - 1463
  • [6] Simplification to dual therapy containing lamivudine and raltegravir or dolutegravir in HIV-infected patients on virologically suppressive antiretroviral therapy
    Calza, Leonardo
    Colangeli, Vincenzo
    Borderi, Marco
    Testi, Diletta
    Granozzi, Bianca
    Bon, Isabella
    Re, Maria Carla
    Viale, Pierluigi
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2020, 75 (11) : 3327 - 3333
  • [7] Substituting Generic Lamivudine for Emtricitabine in Virologically Suppressed HIV-Infected Patients
    Harzke, Amy Jo
    Diaz, Maria
    Tong, Emily
    Baillargeon, Gwen
    Zepeda, Stephanie
    Koranek, Angela
    Sandmann, Robert
    JOURNAL OF CORRECTIONAL HEALTH CARE, 2018, 24 (04) : 371 - 381
  • [8] Simplification to a dual regimen with darunavir/ritonavir plus lamivudine or emtricitabine in virologically-suppressed HIV-infected patients
    Fabbiani, Massimiliano
    Di Giambenedetto, Simona
    Poli, Andrea
    Borghetti, Alberto
    Castagna, Antonella
    Mondi, Annalisa
    Galizzi, Nadia
    Maillard, Myriam
    Gori, Andrea
    Cauda, Roberto
    De Luca, Andrea
    Gianotti, Nicola
    JOURNAL OF INFECTION, 2016, 73 (06) : 619 - 623
  • [9] Dual therapy with etravirine plus raltegravir for virologically suppressed HIV-infected patients: a pilot study
    Monteiro, Polyana
    Perez, Inaki
    Laguno, Montserrat
    Martinez-Rebollar, Maria
    Gonzalez-Cordon, Ana
    Lonca, Montserrat
    Mallolas, Josep
    Blanco, Jose L.
    Gatell, Jose M.
    Martinez, Esteban
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2014, 69 (03) : 742 - 748
  • [10] Long-term data on the efficacy and tolerability of lamivudine plus dolutegravir as a switch strategy in a multi-centre cohort of HIV-1-infected, virologically suppressed patients
    Baldin, Gianmaria
    Ciccullo, Arturo
    Rusconi, Stefano
    Capetti, Amedeo
    Sterrantino, Gaetana
    Colafigli, Manuela
    d'Ettorre, Gabriella
    Giacometti, Andrea
    Cossu, Maria Vittoria
    Borghetti, Alberto
    Gennari, William
    Mussini, Cristina
    Borghi, Vanni
    Di Giambenedetto, Simona
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2019, 54 (06) : 728 - 734